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The Chemical and Veterinary Test Agency (CVUA) Stuttgart has detected glycidol fatty acid 
esters in refined vegetable fats on a palm oil base. The analytical methods currently available 
do not, however, permit the determination, merely the estimation of the exact levels. Fur-
thermore, we do not know what levels of glycidol are released from the glycidol fatty acid 
esters during digestion in humans. Based on findings from animal experiments, glycidol is 
classified as probably carcinogenic to humans.  
 
Because of this major hazard potential and because refined edible fats are used in products 
like margarine and in infant formula, too, the Federal Institute for Risk Assessment (BfR) 
takes the findings of CVUA Stuttgart seriously and presents its initial evaluation of the as-
sessment whether the detected ester-bound glycidol could constitute a threat to health. This 
evaluation is based on the worst case scenario that glycidol is released fully during digestion 
from the fatty acid esters and is then available in the organism. As the exact levels of glycidol 
fatty acid esters could not be reliably determined up to now in vegetable fats, BfR adopts the 
hypothetical assumption that one kilogram of edible fat contains one milligram glycidol. 
 
Based on this calculation, BfR comes to the conclusion that infants who are fed exclusively 
industrially prepared infant milk formula would take in harmful levels of glycidol. As there is 
no alternative to infant milk formula with refined fats for infants who are not exclusively 
breastfed, the manufacturers of these products must do everything they can to reduce the 
levels of glycidol fatty acid esters as far as possible. In order to obtain robust exposure data 
for reliable risk assessment, BfR is of the opinion that there is an urgent need for the devel-
opment and validation of a suitable detection method for glycidol fatty acid esters. Likewise, 
there is a need for research on the conversion of glycidol fatty acid esters into glycidol in the 
human body.  
 
At the present time, the detection of glycidol fatty acid esters in refined vegetable fats has no 
impact on the fundamental statements on the risk assessment of 3-MCPD fatty acid esters 
which also occur in these fats.   
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